Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-07-21
2000-02-22
Ulm, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 12, 530300, 530326, 530350, 530399, A61K 3816, A61K 3818, C07K 1447, C07K 1450
Patent
active
060280581
ABSTRACT:
Methods are provided to regulate the trafficking of nuclear proteins, including the high molecular weight forms of FGF-2, to the nucleus. A nuclear trafficking component, which is approximately 29 kD, is identified as binding to and regulating nuclear localization of FGF-2. Inhibitors of the binding of the 29 kD component and FGF-2 are provided.
REFERENCES:
patent: 5217889 (1993-06-01), Roninson et al.
Gauthier-Rouviere et al., "The Serum Response Factor Nuclear Localization Signal: General Implications for Cyclic AMP-Dependent Protein Kinase Activity in Control of Nuclear Translocation," Molecular And Cellular Biology 15(1): 433-444, 1995.
Leukel and Jost, "Two conserved serines in the nuclear localization signal flanking region are involoved in the nuclear targeting of human lamin A," European Journal of Cell Biology 68: 133-142, 1995.
Mhashilkar et al., "Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies," The EMBO Journal 14(7): 1542-1551, 1995.
Pintucci et al., "Methylation of High Molecular Weight Fibroblast Growth Factor-2 Determines Post-translational Increases in Molecular Weight and Affects Its Intracellular Distribution," Molecular biology of the Cell 7: 1249-1258, 1996.
Nikolakaki et al., "A Nuclear Envelope-associated Kinase Phosphorylates Arginine-Serine Motifs and Modulates Interactions between the Lamin B Receptor and Other Nuclear Proteins," Journal of Biological Chemistry 271(14): 8365-8372, 1996.
Yu et al., "Molecular Cloning and Characterization of a Cellular Protein That Interacts with the Human Immunodeficiency Virus Type 1 Tat Transactivator and Encodes a Strong Transcriptional Activation Domain," Journal of Virology 69(5): 3007-3016, 1995.
Tange et al., "In Vitro Interaction between Human Immunodeficiency Virus Type 1 Rev Protein and Splicing Factor ASF/SF2-associated Protein, p. 32," Journal of Biological Chemistry 271(17): 10066-10072, 1996.
Deb and Datta, "Molecular Cloning of Human Fibroblast Hyaluronic Acid-binding Protein Confirms Its Identity with P-32, a Protein Co-purified with Splicing Factor SF2," Journal of Biological Chemistry 271(4): 2206-2212, 1996.
Florkiewicz et al., "Multiple Forms of bFGF: Differential Nuclear and Cell Surface Localization," Growth Factors 4: 265-275, 1991.
Krainer et al., "Functional Expression of Cloned Human Splicing Factor SF2: Homology to RNA-Binding Proteins, U1 70K, and Drosophila Splicing Regulators," Cell 66: 383-394, 1991.
Honore et al., "Cloning and expression of a cDNA covering the complete coding region of the P32 subunit of human pre-mRNA splicing factor SF2," Gene 134: 283-287, 1993.
Mignatti and Rifkin, "Release of Basic Fibroblast Growth Factor, an Angiogenic Factor Devoid of Secretory Signal Sequence: A Trivial Phenomenon or a Novel Secretion Mechanism?" Journal of Cellular Biochemistry 47: 201-207, 1991.
Luo et al., "Cellular Protein Modulates Effects of Human Immunodeficiency Virus Type 1 Rev," Jouranl of Virology 68(6): 3850-3856, 1994.
Roninson, et al., "Molecular determinants of drug response: a genetic suppressor element analysis," Anti-Cancer Drugs 7(suppl 3): 83-91, 1996.
Gudkov, A., "Drug Sensitivity Genes: Identification and Analysis Using the Genetic Suppressor Element Approach," in Multidrug Resistance in Cancer Cells, Gupta and Tsuruo (eds.), John Wiley & Sons, Ltd., 1996, 193-215.
Ciblex Corporation
Saoud Christine
Ulm John
LandOfFree
Methods and compositions for regulating nuclear trafficking of p does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for regulating nuclear trafficking of p, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for regulating nuclear trafficking of p will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-520611